Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection? - Chae, Young Kwang; Pan, Alan; Davis, Andrew A.; Raparia, Kirtee; Mohindra, Nisha A.; Matsangou, Maria; Giles, Francis J. (Clinical lung cancer, 2016)
Keywords: Antineoplastic Agents - pharmacology; B7-H1 Antigen - antagonists & inhibitors; B7-H1 Antigen - immunology; Biomarkers; Biomarkers, Tumor - immunology; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - pathology; Gene Expression Regulation, Neoplastic; Hematology, Oncology and Palliative Medicine; Humans; Immunotherapy; Immunotherapy - methods; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - pathology; NSCLC; Patient Selection; Programmed Cell Death 1 Receptor - antagonists & inhibitors; Programmed Cell Death 1 Receptor - immunology; Programmed cell death-1 protein ligand; Programmed cell death-1 protein receptor; Pulmonary/Respiratory; Tumor Microenvironment; Biomarkers; NSCLC; Programmed cell death-1 protein receptor; Programmed cell death-1 protein ligand; Immunotherapy